Fr. 139.00

New Developments in Hodgkin's Lymphoma, An Issue of Hematology/Oncology Clinics of North America: Volume 40-2

English · Hardback

Will be released 28.04.2026

Description

Read more










In this issue of Hematology/Oncology Clinics, guest editors Drs. Alex F. Herrera and Alison J. Moskowitz bring their considerable expertise to the topic of New Developments in Hodgkin's Lymphoma. Top experts focus on how advances in our understanding of Hodgkin’s lymphoma biology, diagnostics, and novel therapies have revolutionized the management of Hodgkin’s lymphoma.

  • Contains 13 relevant, practice-oriented topics including updates in our understanding of the biology of classic Hodgkin’s lymphoma; new standards in advanced stage Hodgkin’s lymphoma: selecting a novel regimen; adolescents and young adults with Hodgkin’s lymphoma; management of classic Hodgkin’s lymphoma in pregnancy; health disparities in classic Hodgkin’s lymphoma; and more
  • Provides in-depth clinical reviews on new developments in Hodgkin's lymphoma, offering actionable insights for clinical practice
  • Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews


Product details

Assisted by Alex F. Herrera (Editor), Alison J. Moskowitz (Editor)
Publisher Elsevier
 
Languages English
Product format Hardback
Release 28.04.2026
 
EAN 9780443472329
ISBN 978-0-443-47232-9
Series The Clinics: Internal Medicine
Subjects Natural sciences, medicine, IT, technology > Medicine > Clinical medicine

MEDICAL / Hematology, Haematology

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.